You are here:
GAVI support for new and underused vaccines has contributed to the immunisation of an additional 370 million children.
GAVI plans to support the rollout of pneumococcal vaccines in over 40 countries by 2015.
Ten GAVI-eligible countries have added rotavirus vaccine to their immunisation programmes.
MenAfriVac vaccine could prevent 150,000 deaths by 2015 in Africa's "meningitis belt".
GAVI supports inactivated polio vaccine as part of routine immunisation programmes.
GAVI funds JE catch up campaigns. Countries self-finance the vaccine for routine immunisation.
Countries use GAVI's HSS funding to target 'bottlenecks' in their health system.
Over the course of a decade, the weighted average price of pentavalent vaccine dropped by 39% from US$ 3.56 in 2003 to US$ 2.17 per dose in 2012, with a lowest ever price of US$ 1.19 per dose from one supplier in 2013.
© GAVI Alliance 2014
modal window here